Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate

NCT02969044 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer